During the month of June, a total of 1 054 cases of measles were reported across seventeen countries in the EU/EEA, which is a decrease from the 1467 cases reported during the month of May.
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
According to the latest Communicable Diseases Threats Report (CDTR) with the most recent data collected through epidemic intelligence, Romania (4 317), France (2 588), Greece (2 238) and Italy (1 716) have reported the highest number of cases in 2018. To date, 31 deaths have also been reported across the region in 2018.
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
Measles cases continue to increase in a number of EU/EEA countries according to the most recent measles data collected by ECDC through epidemic intelligence and published in the Communicable Diseases Threats Report (CDTR) today.
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens?